Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6221)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2014 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li CZ, Hu JJ, Xue JY, Yin W, Liu YY, Fan WH, Xu H, Liang XS. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B. World J Gastroenterol 2014; 20(28): 9486-9496 [PMID: 25071343 DOI: 10.3748/wjg.v20.i28.9486] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i28/9486.htm |
| Number | Citing Articles |
| 1 |
Lauke L Boeijen, Michelle Spaan, André Boonstra. The Effects of Nucleoside/Nucleotide Analogues on Host Immune Cells: The Baseline for Future Immune Therapy for HBV?. Antiviral Therapy 2020; 25(4): 181 doi: 10.3851/IMP3364
|
| 2 |
Marina Manea, Dimitri Apostol, Ileana Constantinescu. The Connection between MiR-122 and Lymphocytes in Patients Receiving Treatment for Chronic Hepatitis B Virus Infection. Microorganisms 2023; 11(11): 2731 doi: 10.3390/microorganisms11112731
|
| 3 |
Zhi-Qiang Zou, Li Wang, Kai Wang, Ji-Guang Yu. Innate immune targets of hepatitis B virus infection. World Journal of Hepatology 2016; 8(17): 716-725 doi: 10.4254/wjh.v8.i17.716
|
| 4 |
Urbano Sbarigia, Talitha Vincken, Peter Wigfield, Mahmoud Hashim, Bart Heeg, Maarten Postma. A comparative network meta-analysis of standard of care treatments in treatment-naïve chronic hepatitis B patients. Journal of Comparative Effectiveness Research 2020; 9(15): 1051 doi: 10.2217/cer-2020-0068
|
| 5 |
Lai Wei, Jia-Horng Kao. Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis B. Current Medical Research and Opinion 2017; 33(3): 495 doi: 10.1080/03007995.2016.1264932
|
| 6 |
A. Velay, H. Jeulin, M. Eschlimann, B. Malvé, F. Goehringer, M. Bensenane, J‐P. Frippiat, P. Abraham, A. M. Ismail, J. M. Murray, C. Combet, F. Zoulim, J‐P. Bronowicki, E. Schvoerer. Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy. Journal of Viral Hepatitis 2016; 23(5): 387 doi: 10.1111/jvh.12498
|
| 7 |
Xinzhi Wang, Luyong Zhang, Zhenzhou Jiang. T‐helper cell‐mediated factors in drug‐induced liver injury. Journal of Applied Toxicology 2015; 35(7): 695 doi: 10.1002/jat.3115
|
| 8 |
Hao Feng, Jie Yin, Ya-Ping Han, Xiao-Ying Zhou, Su Chen, Li Yang, Jin-Rui Yan, Guo-Xin Zhang. Sustained Changes of Treg and Th17 Cells During Interferon-α Therapy in Patients with Chronic Hepatitis B. Viral Immunology 2015; 28(8): 412 doi: 10.1089/vim.2015.0024
|
| 9 |
Tongjing Xing, Hongtao Xu, Lin Cao, Maocong Ye, Ferruccio Bonino. HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis. PLOS ONE 2017; 12(1): e0169444 doi: 10.1371/journal.pone.0169444
|
| 10 |
Y.R. Zhang, B. Li, C.X. Wang, N. Zhou, W. Qi, X.L. Li, L.Y. Wu, S.F. Wei, Y.D. Zhang. Influence of Treg cells and HBV genotype on sustained response and drug resistance in the treatment with nucleoside drugs. Brazilian Journal of Medical and Biological Research 2017; 50(3) doi: 10.1590/1414-431x20165796
|
| 11 |
Nianqiu Liu, Bin Liu, Li Zhang, Hu Li, Zhiwei Chen, Aoran Luo, Min Chen, Mingli Peng, Wenwei Yin, Hong Ren, Peng Hu. Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg. International Immunopharmacology 2018; 62: 59 doi: 10.1016/j.intimp.2018.06.043
|
| 12 |
Lucile Dumolard, Caroline Aspord, Patrice N. Marche, Zuzana Macek Jilkova. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1148111
|